Comparison of the Dexamethasone-Suppressed Corticotropin-Releasing Hormone Test and Low-Dose Dexamethasone Suppression Test in the Diagnosis of Cushing’s Syndrome
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Context: The low-dose dexamethasone suppression test (LDDST) is widely used in confirming a diagnosis of Cushing’s syndrome. CRH administration at the end of an LDDST has been reported to improve the diagnostic accuracy of this test. Objective: Our objective was to assess whether CRH administration after a standard LDDST (LDDST-CRH test) improves diagnostic accuracy in Cushing’s syndrome. Design, Setting, and Participants: Thirty-six individuals with a clinical suspicion of Cushing’s syndrome each completed a standard LDDST and an LDDST-CRH test at Hammersmith Hospitals NHS Trust, London. The LDDST involved administration of 0.5 mg oral dexamethasone given 6-hourly for 48 h. Serum cortisol was measured 6 h after the last dose of dexamethasone, with a value of 50 nmol/liter or below excluding Cushing’s syndrome. Immediately after this, the LDDST-CRH test commenced with administration of a ninth dose of 0.5 mg dexamethasone. Exactly 2 h later, 100 μg human-sequence CRH was administered. Serum cortisol was measured 15 min after the CRH injection, with a value of less than 38 nmol/liter also excluding Cushing’s syndrome. Main Outcome Measure: Diagnosis or exclusion of Cushing’s syndrome was the main outcome measure. Results: Twelve subjects were diagnosed with Cushing’s syndrome (eight Cushing’s disease and four primary adrenal). The sensitivity of the LDDST in diagnosing Cushing’s syndrome was 100%, with a specificity of 88%. In contrast, although the sensitivity of the LDDST-CRH test was also 100%, specificity was reduced at 67%. These results give a positive predictive value of 80% for the LDDST and 60% for the LDDST-CRH test. Conclusion: This small study suggests that the addition of CRH to the LDDST does not improve the diagnostic accuracy of the standard LDDST in Cushing’s syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833
Wood, P. J., Barth, J. H., Freedman, D. B., Perry, L., & Sheridan, B. (1997) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/000456329703400302 · Cited by 190 · cited 2×
“5 mg dexamethasone is administered orally at strict 6-hourly intervals for 48 h, with a cutoff value for suppression of serum cortisol to 50 nmol/liter or below being 98% sensitive for the diagnosis of Cushing’s syndrome (6).”
Method
Research works printed but not linked: 12
- Allison, 1999, Annual deaths attributable to obesity in the United States, JAMA, 282, 1530, 10.1001/jama.282.16.1530 · DOI · Paper page
- Brown, 1997, Science, medicine, and the future. Hypertension, BMJ, 314, 1258, 10.1136/bmj.314.7089.1258 · doi:10.1136/bmj.314.7089.1258
- Abuissa, 2005, Strategies to prevent type 2 diabetes, Curr Med Res Opin, 21, 1107, 10.1185/030079905X50606 · DOI
- Liddle, 1960, Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndome, J Clin Endocrinol Metab, 20, 1539, 10.1210/jcem-20-12-1539 · DOI · Paper page
- Newell-Price, 1995, A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome, Clin Endocrinol (Oxf), 43, 545, 10.1111/j.1365-2265.1995.tb02918.x · DOI · Paper page
- Caro, 1978, “Normal suppression” to dexamethasone in Cushing’s disease: an expression of decreased metabolic clearance for dexamethasone, J Clin Endocrinol Metab, 47, 667, 10.1210/jcem-47-3-667 · DOI
- Kapcala, 1984, Cushing’s disease with ‘normal suppression’ due to decreased dexamethasone clearance, Arch Intern Med, 144, 636, 10.1001/archinte.1984.00350150250051 · doi:10.1001/archinte.1984.00350150250051
- Yanovski, 1998, The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing’s disease from normal physiology, J Clin Endocrinol Metab, 83, 348
- Swets, 1988, Measuring the accuracy of diagnostic systems, Science, 240, 1285, 10.1126/science.3287615 · DOI · Paper page
- Pecori Giraldi, 2005, Program of the 87th Annual Meeting of The Endocrine Society, 85
- Trainer, 1995, A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis, J Clin Endocrinol Metab, 80, 412
- Lowy, 1987, Dexamethasone bioavailability: implications for DST research, Biol Psychiatry, 22, 373, 10.1016/0006-3223(87)90155-7 · DOI
Cited by
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
Accuracy of Diagnostic Tests for Cushing’s Syndrome: A Systematic Review and Metaanalyses
Elamin, M. B., Murad, M. H., Mullan, R., Erickson, D., Harris, K., Nadeem, S., Ennis, R., Erwin, P. J., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0139 · Cited by 222
Pecori Giraldi, F., Pivonello, R., Ambrogio, A. G., De Martino, M. C., De Martin, M., Scacchi, M., Colao, A., Toja, P. M., Lombardi, G., & Cavagnini, F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02717.x · Cited by 141
Metadata
- Authors
- Martin, N. M., Dhillo, W. S., Banerjee, A., Abdulali, A., Jayasena, C. N., Donaldson, M., Todd, J. F., & Meeran, K.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-07-01
- Volume
- 91
- Issue
- 7
- Pages
- 2582-2586
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2115202883
- Cited by
- 71
- References
- 3
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of the Dexamethasone-Suppressed Corticotropin-Releasing Hormone Test and Low-Dose Dexamethasone Suppression Test in the Diagnosis of Cushing’s Syndrome. https://app.cochat.ai/papers/10.1210/jc.2005-2143
- The paper
- Martin, N. M., Dhillo, W. S., Banerjee, A., Abdulali, A., Jayasena, C. N., Donaldson, M., Todd, J. F., & Meeran, K. (2006). Comparison of the Dexamethasone-Suppressed Corticotropin-Releasing Hormone Test and Low-Dose Dexamethasone Suppression Test in the Diagnosis of Cushing’s Syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2005-2143
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.